AME posts 62% rise in H1 2022 profit to SAR 15.4 mln

AME posts 62% rise in H1 2022 profit to SAR 15.4 mln

21/08/2022 Argaam Exclusive

View other reports

AME Company for Medical Supplies posted a 62% rise in H1 2022 net profit after Zakat and tax to SAR 15.4 million, from SAR 9.5 million a year earlier.



Financials (M)

Item 6m 2021 6m 2022 Change‬
Revenues 69.78 108.35 55.3 %
Gross Income 32.00 48.86 52.7 %
Operating Income 13.27 17.25 30.0 %
Net Income 7.50 15.38 105.1 %
Average Shares 7.00 7.00 -
EPS (Riyals) 1.07 2.20 105.1 %

The profit growth was driven by an increase of SAR 54.28 million year-on-year (YoY) in the sales of medical supplies and devices. This surge resulted from the company’s acquisition of a larger market share, thanks to its participation in local and international conferences, exertion of more efforts to advertise and market its products, as well as the appointment of new employees in the sales and marketing departments to serve customers faster.



Current Half Annual Comparison (M)

Compared With The
Item H1 2021 H1 2022 Change‬
Revenues 69.78 108.35 55.3 %
Gross Income 32.00 48.86 52.7 %
Operating Income 13.27 17.25 30.0 %
Net Income 7.50 15.38 105.1 %
Average Shares 7.00 7.00 -
EPS (Riyals) 1.07 2.20 105.1 %

Shareholders’ equity, after minority interest, rose to SAR 96.942 million as of June 30, 2022, from SAR 93.414 million in the prior-year period.

View More Financial Results

 


Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
H1 2013 - - - - - -
H2 2013 - - - - - -
H1 2014 - - - - - -
H2 2014 - - - - - -
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 44.66 - 22.01 - 4.94 -
H2 2020 76.94 - 33.27 - 17.70 -
H1 2021 69.78 56.2 % 32.00 45.4 % 13.27 168.5 %
H2 2021 81.60 6.1 % 37.54 12.8 % 15.70 (11.3 %)
H1 2022 108.35 55.3 % 48.86 52.7 % 17.25 30.0 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
H1 2013 - - - - - -
H2 2013 - - - - - -
H1 2014 - - - - - -
H2 2014 - - - - - -
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 4.18 - 0.60 - 4.18 0.60
H2 2020 16.89 - 2.41 - 16.89 2.41
H1 2021 7.50 79.3 % 1.07 (4.32) 11.82 1.69
H2 2021 13.72 (18.7 %) 1.96 (0.15) 13.87 1.98
H1 2022 15.38 105.1 % 2.20 - 15.38 2.20

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
H1 2013 - - -
H2 2013 - - -
H1 2014 - - -
H2 2014 - - -
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 45.46 % 18.86 % 17.33 %
H1 2021 44.49 % 21.31 % 19.57 %
H2 2021 45.94 % 19.44 % 16.97 %
H1 2022 45.49 % 17.71 % 15.40 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
H1 2013 - - - -
H2 2013 - - - -
H1 2014 - - - -
H2 2014 - - - -
H1 2015 - - - -
H2 2015 - - - -
H1 2016 - - - -
H2 2016 - - - -
H1 2017 - - - -
H2 2017 - - - -
H1 2018 - - - -
H2 2018 - - - -
H1 2019 - - - -
H2 2019 - - - -
H1 2020 7.00 - - 3.20
H2 2020 7.00 3.01 3.01 9.08
H1 2021 7.00 3.48 4.10 11.72
H2 2021 7.00 3.03 3.67 13.34
H1 2022 7.00 4.16 4.18 13.79

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
H1 2013 - - -
H2 2013 - - -
H1 2014 - - -
H2 2014 - - -
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 10.46 10.41 3.15

Business Segments (Million)

Compared With The
Period Medical supplies Medical equipment sales Real Estate Management Others
Q2 2020 34.27 8.38 1.86 0.15
Q4 2020 65.25 9.20 2.45 0.04
Q2 2021 51.04 15.33 3.24 0.18
Q4 2021 67.96 11.75 2.07 -
Q2 2022 83.97 21.46 2.76 0.15


Financial Ratios
Current
Market Cap (M Riyal) 739.20
Enterprise Value (EV) (M) 695.80
Shares Outstanding ((M)) 7.00
Book Value (BV) ( Riyal) 18.17
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 22.06
Price/book 5.81
more

Share Price

AME Company for Medical Supplies
105.60
0.00 0.00 %

AME Company for Medical Supplies (AME)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.